| Novel risk factors related to cancer in scleroderma D Bernal-Bello, JG de Tena, A Guillén-del Castillo, A Selva-O'Callaghan, ... Autoimmunity Reviews 16 (5), 461-468, 2017 | 70 | 2017 |
| GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19 E Pairo-Castineira, K Rawlik, AD Bretherick, T Qi, Y Wu, I Nassiri, ... Nature 617 (7962), 764-768, 2023 | 53 | 2023 |
| Imatinib for COVID-19: a case report A Morales-Ortega, D Bernal-Bello, C Llarena-Barroso, B Frutos-Pérez, ... Clinical Immunology (Orlando, Fla.) 218, 108518, 2020 | 43 | 2020 |
| Imatinib might constitute a treatment option for lung involvement in COVID-19 D Bernal-Bello, B Jaenes-Barrios, A Morales-Ortega, JM Ruiz-Giardin, ... Autoimmunity Reviews 19 (7), 102565, 2020 | 26 | 2020 |
| Systemic sclerosis, breast cancer and calcium channel blockers: a new player on the scene? D Bernal-Bello, J Garcia de Tena, C Simeon-Aznar, V Fonollosa-Pla Autoimmunity Reviews 13 (8), 880-881, 2014 | 16 | 2014 |
| Prognostic factors and combined use of tocilizumab and corticosteroids in a Spanish cohort of elderly COVID‐19 patients MA Duarte‐Millán, N Mesa‐Plaza, M Guerrero‐Santillán, ... Journal of Medical Virology 94 (4), 1540-1549, 2022 | 15 | 2022 |
| Spanish scleroderma risk score (RESCLESCORE) to predict 15-year all-cause mortality in scleroderma patients at the time of diagnosis based on the RESCLE cohort: derivation and … M Rubio-Rivas, X Corbella, A Guillén-del-Castillo, CT Vilella, ... Autoimmunity Reviews 19 (5), 102507, 2020 | 15 | 2020 |
| Imatinib in COVID-19: hope and caution D Bernal-Bello, A Morales-Ortega, AI Farfán-Sedano, JG de Tena, ... The Lancet Respiratory Medicine 9 (9), 938-939, 2021 | 13 | 2021 |
| Comparative study of vaccinated and unvaccinated hospitalised patients: A retrospective population study of 500 hospitalised patients with SARS-CoV-2 infection in a Spanish … JM Ruiz-Giardin, M Rivilla, N Mesa, A Morales, L Rivas, A Izquierdo, ... Viruses 14 (10), 2284, 2022 | 10 | 2022 |
| Early clinical experience with imatinib in COVID-19: Searching for a dual effect A Morales-Ortega, L Rivas-Prado, B Frutos-Pérez, B Jaenes-Barrios, ... The Journal of Infection 82 (5), 186, 2021 | 9 | 2021 |
| HLA‐A*11:01 and HLA‐C*04:01 are associated with severe COVID‐19 P Castro‐Santos, A Rojas‐Martinez, JA Riancho, P Lapunzina, C Flores, ... HLA 102 (6), 731-739, 2023 | 7 | 2023 |
| Dosis altas de corticoides sistémicos en pacientes ingresados por exacerbación de enfermedad pulmonar obstructiva crónica. Un estudio de cohortes JA Rueda-Camino, D Bernal-Bello, J Canora-Lebrato, L Velázquez-Ríos, ... Revista Clínica Española 217 (9), 504-509, 2017 | 6 | 2017 |
| Baricitinib or imatinib in hospitalized COVID‐19 patients: Results from COVINIB, an exploratory randomized clinical trial A Morales‐Ortega, AI Farfán‐Sedano, JV San Martín‐López, ... Journal of Medical Virology 95 (2), e28495, 2023 | 5 | 2023 |
| High doses of systemic corticosteroids in patients hospitalized for exacerbation of chronic obstructive pulmonary disease. A cohort study JA Rueda-Camino, D Bernal-Bello, J Canora-Lebrato, L Velázquez-Ríos, ... Revista Clínica Española (English Edition) 217 (9), 504-509, 2017 | 5 | 2017 |
| COVID‐19 in patients with hematological malignancies: Considering the role of tyrosine kinase inhibitors A Morales‐Ortega, JG de Tena, B Frutos‐Pérez, B Jaenes‐Barrios, ... Cancer 127 (11), 1937, 2021 | 4 | 2021 |
| Afectación atípica de palmas y plantas en la neumonía por varicela D Bernal-Bello, J García de Tena, L Abejón-López, T Megino-Moreno, ... Revista Clínica Española 212 (4), 0-0, 2012 | 4 | 2012 |
| Hyperparathyroidism shows its hand: findings of osteitis fibrosa cystica L Rivas-Prado, A Morales-Ortega, S Allodi-de la Hoz, D Bernal-Bello The Lancet 397 (10288), 1914, 2021 | 3 | 2021 |
| Serum CA-125 and renal impairment in patients undergoing hyperthermic intraperitoneal chemotherapy D Bernal-Bello, I Guerra-Pérez, L Alegre-Zahonero biomedical journal 45 (5), 847, 2022 | 2 | 2022 |
| Primary liver lymphoma and systemic sclerosis V García-Bermúdez, A Morales-Ortega, MI Jaquero-Valero, R Khedaoui, ... Rheumatology 61 (8), e247-e248, 2022 | 2 | 2022 |
| Antibody formation against SARS-CoV-2 in imatinib-treated COVID-19 patients A Morales-Ortega, AI Farfán-Sedano, A Izquierdo-Martínez, ... The Journal of Infection 84 (2), 248, 2022 | 2 | 2022 |
